Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease

This publication has 111 references indexed in Scilit:

• Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
  Journal of Molecular Biology, 2011
• Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
  Molecular Genetics and Metabolism, 2011
• Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
  Neurobiology of Disease, 2011
• Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease
  ACS Chemical Neuroscience, 2011
• Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
  Neurobiology of Disease, 2010
• LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
  Neurobiology of Disease, 2010
• From Promiscuity to Precision: Protein Phosphatases Get a Makeover
  Molecular Cell, 2009
• Activation of Protein Phosphatase 1 by a Small Molecule Designed to Bind to the Enzyme's Regulatory Site
  Chemistry & Biology, 2008
• α-synuclein locus duplication as a cause of familial Parkinson's disease
  The Lancet, 2004
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
  Annals of Neurology, 2003